Labcorp Holdings Stock (NYSE:LH)

Forecast Revenue Ownership Financials Chart Transcripts

Previous Close

$268.70

52W Range

$209.38 - $293.72

50D Avg

$271.16

200D Avg

$266.72

Market Cap

$22.42B

Avg Vol (3M)

$715.07K

Beta

0.97

Div Yield

$2.88 (1.07%)

LH Company Profile

Labcorp Holdings, Inc. provides laboratory services to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.

Industry

Medical - Equipment & Services

Sector

Healthcare

Exchange

NYSE

ADR

-

Country

US

Employees

60,900

IPO Date

Mar 29, 1990

Website

LH Performance

Revenue Breakdown

Revenue Breakdown by Product/Service

Product/Service	Dec 25	Dec 24	Dec 22
LabCorp Diagnostics	$10.88B	$10.14B	-
Diagnostics	-	-	$9.20B
Drug Development	-	-	$5.71B

Fiscal year ends in Dec 25 | Currency in USD

LH Financial Summary

	Dec 25	Dec 24	Dec 23
Revenue	$13.95B	$13.01B	$12.16B
Operating Income	$1.52B	$1.09B	$725.60M
Net Income	$876.50M	$746.00M	$418.00M
EBITDA	$2.20B	$1.81B	$1.35B
Basic EPS	$10.54	$8.89	$4.80
Diluted EPS	$10.46	$8.84	$4.77

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts

Q4 25Feb 17, 26 | 9:00 AM

Q3 25Oct 28, 25 | 9:00 AM

Q2 25Jul 24, 25 | 9:00 AM

Peer Comparison

Ticker	Company
WAT	Waters Corporation
BIIB	Biogen Inc.
ZBH	Zimmer Biomet Holdings, Inc.
INCY	Incyte Corporation
WST	West Pharmaceutical Services, Inc.
DGX	Quest Diagnostics Incorporated
STE	STERIS plc
ILMN	Illumina, Inc.
DXCM	DexCom, Inc.
UTHR	United Therapeutics Corporation